{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:13:36Z","timestamp":1787868816506,"version":"build-2784847793"},"reference-count":48,"publisher":"Japan Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1507\/endocrj.ej20-0050","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T22:04:48Z","timestamp":1587593088000},"page":"827-840","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy and safety of stem cells transplantation in patients with type 1 diabetes mellitus\u2014a systematic review and meta-analysis"],"prefix":"10.1507","volume":"67","author":[{"given":"Qian","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital with Nanjing Medical University, Nanjing Medical University, Nanjing, 210029, China"},{"name":"Department of Endocrinology, Taikang Xianlin Drum Tower Hospital, Nanjing University School of Medicine, Nanjing, 210046, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital with Nanjing Medical University, Nanjing Medical University, Nanjing, 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital with Nanjing Medical University, Nanjing Medical University, Nanjing, 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuqin","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital with Nanjing Medical University, Nanjing Medical University, Nanjing, 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital with Nanjing Medical University, Nanjing Medical University, Nanjing, 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital with Nanjing Medical University, Nanjing Medical University, Nanjing, 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital with Nanjing Medical University, Nanjing Medical University, Nanjing, 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Pathak V, Pathak NM, O\u2019Neill CL, Guduric-Fuchs J, Medina RJ (2019) Therapies for type 1 diabetes: current scenario and future perspectives. Clin Med Insights Endocrinol Diabetes 12: 1179551419844521.","DOI":"10.1177\/1179551419844521"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Bretzel RG, Jahr H, Eckhard M, Martin I, Winter D, et al. (2007) Islet cell transplantation today. Langenbecks Arch Surg 392: 239\u2013253.","DOI":"10.1007\/s00423-007-0183-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Qi X, Guo X, Su C (2015) Clinical outcomes of the transplantation of stem cells from various human tissue sources in the management of liver cirrhosis: a systematic review and meta-analysis. Curr Stem Cell Res Ther 10: 166\u2013180.","DOI":"10.2174\/1574888X09666141112114011"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Tao H, Li Y, Wang T, Zhou C (2018) Umbilical cord blood stem cells transplantation as an adjunctive treatment strategy for liver cirrhosis in Chinese population: a meta-analysis of effectiveness and safety. Ther Clin Risk Manag 14: 417\u2013440.","DOI":"10.2147\/TCRM.S157603"},{"key":"5","unstructured":"5 Ma XR, Tang YL, Xuan M, Chang Z, Wang XY, et al. (2015) Transplantation of autologous mesenchymal stem cells for end-stage liver cirrhosis: a meta-analysis based on seven controlled trials. Gastroenterol Res Pract 2015: 908275."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Kim G, Eom YW, Baik SK, Shin Y, Lim YL, et al. (2015) Therapeutic effects of mesenchymal stem cells for patients with chronic liver diseases: systematic review and meta-analysis. J Korean Med Sci 30: 1405\u20131415.","DOI":"10.3346\/jkms.2015.30.10.1405"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Dave M, Jaiswal P, Cominelli F (2017) Mesenchymal stem\/stromal cell therapy for inflammatory bowel disease: an updated review with maintenance of remission. Curr Opin Gastroenterol 33: 59\u201368.","DOI":"10.1097\/MOG.0000000000000327"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Jeong H, Yim HW, Park HJ, Cho Y, Hong H, et al. (2018) Mesenchymal stem cell therapy for ischemic heart disease: systematic review and meta-analysis. Int J Stem Cells 11: 1\u201312.","DOI":"10.15283\/ijsc17061"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Chhabra P, Brayman KL (2013) Stem cell therapy to cure type 1 diabetes: from hype to hope. Stem Cells Transl Med 2: 328\u2013336.","DOI":"10.5966\/sctm.2012-0116"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Kakkar A, Sorout A, Tiwari M, Shrivastava P, Meena P, et al. (2018) Current status of stem cell treatment for type i diabetes mellitus. Tissue Eng Regen Med 15: 699\u2013709.","DOI":"10.1007\/s13770-018-0143-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Sordi V, Pellegrini S, Krampera M, Marchetti P, Pessina A, et al. (2017) Stem cells to restore insulin production and cure diabetes. Nutr Metab Cardiovasc Dis 27: 583\u2013600.","DOI":"10.1016\/j.numecd.2017.02.004"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Vanikar AV, Trivedi HL, Thakkar UG (2016) Stem cell therapy emerging as the key player in treating type 1 diabetes mellitus. Cytotherapy 18: 1077\u20131086.","DOI":"10.1016\/j.jcyt.2016.06.006"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Farooq T, Rehman K, Hameed A, Akash MSH (2019) Stem cell therapy and type 1 diabetes mellitus: treatment strategies and future perspectives. Adv Exp Med Biol 1084: 95\u2013107.","DOI":"10.1007\/5584_2018_195"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557\u2013560.","DOI":"10.1136\/bmj.327.7414.557"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177\u2013188.","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, et al. (2009) C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 301: 1573\u20131579.","DOI":"10.1001\/jama.2009.470"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Haller MJ, Wasserfall CH, McGrail KM, Cintron M, Brusko TM, et al. (2009) Autologous umbilical cord blood transfusion in very young children with type 1 diabetes. Diabetes Care 32: 2041\u20132046.","DOI":"10.2337\/dc09-0967"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Vanikar AV, Dave SD, Thakkar UG, Trivedi HL (2010) Cotransplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: a novel therapy for insulin-dependent diabetes mellitus. Stem Cells Int 2010: 582382.","DOI":"10.4061\/2010\/582382"},{"key":"19","unstructured":"19 Gu W, Sun S, Hu J (2010) Efficacy and safety of autologous hematopoietic stem cell transplantation in treating type 1 diabetes mellitus. Chinese Journal of Endocrinology and Metabolism 26: 1023\u20131026 (In Chinese)."},{"key":"20","unstructured":"20 Feng K, Xu YW, Ye FG, Xiao L, Ma XH, et al. (2011) Autologous peripheral blood hematopoietic stem cell transplantation in the treatment of type 1 diabetic mellitus: a report of 16 cases. Zhonghua Yi Xue Za Zhi 91: 1966\u20131969 (In Chinese)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Haller MJ, Wasserfall CH, Hulme MA, Cintron M, Brusko TM, et al. (2011) Autologous umbilical cord blood transfusion in young children with type 1 diabetes fails to preserve c-peptide. Diabetes Care 34: 2567\u20132569.","DOI":"10.2337\/dc11-1406"},{"key":"22","unstructured":"22 Yu W, Gao H, Yu X, Wang L, Yan S, et al. (2011) Umbilical cord mesenchymal stem cells transplantation for newly-onset type 1 diabetes. Journal of Clinical Rehabilitative Tissue Engineering Research 15: 4363\u20134366 (In Chinese)."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Gu W, Hu J, Wang W, Li L, Tang W, et al. (2012) Diabetic ketoacidosis at diagnosis influences complete remission after treatment with hematopoietic stem cell transplantation in adolescents with type 1 diabetes. Diabetes Care 35: 1413\u20131419.","DOI":"10.2337\/dc11-2161"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Li L, Shen S, Ouyang J, Hu Y, Hu L, et al. (2012) Autologous hematopoietic stem cell transplantation modulates immunocompetent cells and improves beta-cell function in Chinese patients with new onset of type 1 diabetes. J Clin Endocrinol Metab 97: 1729\u20131736.","DOI":"10.1210\/jc.2011-2188"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Zhang X, Ye L, Hu J, Tang W, Liu R, et al. (2012) Acute response of peripheral blood cell to autologous hematopoietic stem cell transplantation in type 1 diabetic patient. PLoS One 7: e31887.","DOI":"10.1371\/journal.pone.0031887"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Zhao Y, Jiang Z, Zhao T, Ye M, Hu C, et al. (2012) Reversal of type 1 diabetes <i>via<\/i> islet beta cell regeneration following immune modulation by cord blood-derived multipotent stem cells. BMC Med 10: 3.","DOI":"10.1186\/1741-7015-10-3"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Haller MJ, Wasserfall CH, Hulme MA, Cintron M, Brusko TM, et al. (2013) Autologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin d supplementation for c-peptide preservation in children with type 1 diabetes. Biol Blood Marrow Transplant 19: 1126\u20131129.","DOI":"10.1016\/j.bbmt.2013.04.011"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Hu J, Yu X, Wang Z, Wang F, Wang L, et al. (2013) Long term effects of the implantation of wharton\u2019s jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. Endocr J 60: 347\u2013357.","DOI":"10.1507\/endocrj.EJ12-0343"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Mesples A, Majeed N, Zhang Y, Hu X (2013) Early immunotherapy using autologous adult stem cells reversed the effect of anti-pancreatic islets in recently diagnosed type 1 diabetes mellitus: preliminary results. Med Sci Monit 19: 852\u2013857.","DOI":"10.12659\/MSM.889525"},{"key":"30","unstructured":"30 Wang B, Gao J, Zhang J, Wang L, L L, et al. (2013) Comparison of blood glucose after autologous hematopoietic stem cell transpalntation and insulin therapy in patients with type 1 diabetes by continuous glucose monitoring system. Shanghai Med J 36: 394\u2013397 (In Chinese)."},{"key":"31","doi-asserted-by":"publisher","unstructured":"31 D\u2019Addio F, Valderrama Vasquez A, Ben Nasr M, Franek E, Zhu D, et al. (2014) Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis. Diabetes 63: 3041\u20133046.","DOI":"10.2337\/db14-0295"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Giannopoulou EZ, Puff R, Beyerlein A, von Luettichau I, Boerschmann H, et al. (2014) Effect of a single autologous cord blood infusion on beta-cell and immune function in children with new onset type 1 diabetes: a non-randomized, controlled trial. Pediatr Diabetes 15: 100\u2013109.","DOI":"10.1111\/pedi.12072"},{"key":"33","unstructured":"33 Gu Y, Gong C, Peng X, Wei L, Su C, et al. (2014) Autologous hematopoietic stem cell transplantation and conventional insulin therapy in the treatment of children with newly diagnosed type 1 diabetes: long term follow-up. Chin Med J (Engl) 127: 2618\u20132622."},{"key":"34","unstructured":"34 Hou T, Shi Y (2014) Control study of autologous stem cell transplantation action glycemic control in patients with type 1 diabetes. China Modern Doctor 52: 34\u201337 (In Chinese)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Carlsson PO, Schwarcz E, Korsgren O, Le Blanc K (2015) Preserved beta-cell function in type 1 diabetes by mesenchymal stromal cells. Diabetes 64: 587\u2013592.","DOI":"10.2337\/db14-0656"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Delgado E, Perez-Basterrechea M, Suarez-Alvarez B, Zhou H, Revuelta EM, et al. (2015) Modulation of autoimmune T-cell memory by stem cell educator therapy: phase 1\/2 clinical trial. EBioMedicine 2: 2024\u20132036.","DOI":"10.1016\/j.ebiom.2015.11.003"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Thakkar UG, Trivedi HL, Vanikar AV, Dave SD (2015) Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus. Cytotherapy 17: 940\u2013947.","DOI":"10.1016\/j.jcyt.2015.03.608"},{"key":"38","unstructured":"38 Jia X, Shen S, Li L, Hui H, XU Q, et al. (2015) Clinical efficacy of allogenic mesenchymal stem cells transplantation in patients with ketosis-onset type 1 diabetes mellitus. Chinese Journal of Diabetes Mellitus 7: 425\u2013430 (In Chinese)."},{"key":"39","doi-asserted-by":"publisher","unstructured":"39 Cai J, Wu Z, Xu X, Liao L, Chen J, et al. (2016) Umbilical cord mesenchymal stromal cell with autologous bone marrow cell transplantation in established type 1 diabetes: a pilot randomized controlled open-label clinical study to assess safety and impact on insulin secretion. Diabetes Care 39: 149\u2013157.","DOI":"10.2337\/dc15-0171"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Snarski E, Milczarczyk A, Halaburda K, Torosian T, Paluszewska M, et al. (2016) Immunoablation and autologous hematopoietic stem cell transplantation in the treatment of new-onset type 1 diabetes mellitus: long-term observations. Bone Marrow Transplant 51: 398\u2013402.","DOI":"10.1038\/bmt.2015.294"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Ye L, Li L, Wan B, Yang M, Hong J, et al. (2017) Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus. Stem Cell Res Ther 8: 90.","DOI":"10.1186\/s13287-017-0542-1"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Gu B, Miao H, Zhang J, Hu J, Zhou W, et al. (2018) Clinical benefits of autologous haematopoietic stem cell transplantation in type 1 diabetes patients. Diabetes Metab 44: 341\u2013345.","DOI":"10.1016\/j.diabet.2017.12.006"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Mohamed MT, Embaby EA, Labib A, El-Husseiny M, Khamis H, et al. (2018) Effects of exercise in combination with autologous bone marrow stem cell transplantation for patients with type 1 diabetes. Physiother Theory Pract 35: 1233\u20131242.","DOI":"10.1080\/09593985.2018.1474511"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Ulyanova O, Askarov M, Kozina L, Karibekov T, Shaimardanova G, et al. (2019) Autologous mesenchymal stem cell transplant in patients with type 1 diabetes mellitus. Exp Clin Transplant 17: 236\u2013238.","DOI":"10.6002\/ect.MESOT2018.P100"},{"key":"45","unstructured":"45 Gan J, Wang Y, Zhou X (2018) Stem cell transplantation for the treatment of patients with type 1 diabetes mellitus: a meta-analysis. Exp Ther Med 16: 4479\u20134492."},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Borisov MA, Petrakova OS, Gvazava IG, Kalistratova EN, Vasiliev AV (2016) Stem cells in the treatment of insulin-dependent diabetes mellitus. Acta Naturae 8: 31\u201343.","DOI":"10.32607\/20758251-2016-8-3-31-43"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Schneider A, Rieck M, Sanda S, Pihoker C, Greenbaum C, et al. (2008) The effector T cells of diabetic subjects are resistant to regulation <i>via<\/i> CD4+ foxp3+ regulatory T cells. J Immunol 181: 7350\u20137355.","DOI":"10.4049\/jimmunol.181.10.7350"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Parker MJ, Xue S, Alexander JJ, Wasserfall CH, Campbell-Thompson ML, et al. (2009) Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice. Diabetes 58: 2277\u20132284.","DOI":"10.2337\/db09-0557"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/8\/67_EJ20-0050\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T03:34:37Z","timestamp":1598672077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/8\/67_EJ20-0050\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej20-0050","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}